CRISIL Revises UPL Outlook to Stable, Reaffirms AA+ Rating
CRISIL revised UPL's long-term outlook to Stable with AA+ rating reaffirmed. Short-term rating A1+ reaffirmed for UPL, indicating strong credit quality. Source: ScoutQuest
Stock news timeline · UPL
UPL
News timeline · Last 30 days
24 Aug 2026 – 22 Sep 2026 · Times in IST
- Timeline updates
- 10
- Bullish
- 5
- Neutral
- 4
- Bearish
- 1
- Active days
- 4
News timeline
Showing 10 of 10 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Wednesday, 02 Sep 20261 update
Thursday, 27 Aug 20262 updates
DAM Capital Retains Buy on UPL, Sets ₹870 Target; Advanta IPO May Unlock Value
DAM Capital reaffirms Buy on UPL with ₹870 target citing Advanta's 20%+ growth and Superform's 51% Q1 growth. Group EBITDA rose 15% on 10% revenue growth; 61% HoldCo discount deemed excessive, Advanta IPO may unlock value. Source: Livesquawk
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as Advanta grows 20%+, Superform’s specialty chemicals grew 51% in Q1 and group EBITDA rose 15% on 10% revenue growth, while the 61% HoldCo discount appears excessive and the Advanta IPO could unlock value.
Wednesday, 26 Aug 20262 updates
UPL: Group COO Toshan Tamhane Resigns To Pursue Entrepreneurial Ventures; Effective From August 31, 2026.
UPL COO Toshan Tamhane to Exit by Aug 2026 for Entrepreneurship
UPL Ltd announces COO Toshan Tamhane's exit to pursue entrepreneurship. Tamhane contributed to strategic, digital, and transformation initiatives; exit effective Aug 31, 2026. Source: BSE
Tuesday, 25 Aug 20265 updates
India Bans Carbosulfan, Hits UPL Supply Chain
India bans the import, sale, manufacturing, and distribution of carbosulfan insecticide. The decision impacts the product ecosystem and supply chains linked to UPL Ltd. Source: Livesquawk
India Government Prohibits Imports, Sale, Manufacturing, And Distribution Of Carbosulfan Insecticide (UPL)
UPL: Jefferies on UPL Buy, Target Price Rs 715, citing confidence in 10–14% FY27 growth guidance, expected EBITDA margin improvement from rationalising unprofitable businesses, tight LatAm inventory control amid El Niño, upcoming Advanta IPO marketing and projected 14% FY27E EBITDA growth.
TCS, PB Fintech, UPL, Indian Hotels Get Mixed Ratings; Key Growth Insights
Brokerages spotlight TCS, Indian Hotels, PB Fintech, UPL with varied ratings; TCS's acquisition and PB Fintech’s growth highlighted. Jefferies sees UPL's growth guidance amid EBITDA margin gains; Indian Hotels' Oriental Hotels merger seen as EPS accretive from year one. Source: NDTV Profit
Jefferies Backs UPL: ₹715 Target, 10-14% Growth by FY27
Jefferies advises buying UPL with a ₹715 target; FY27 growth forecast is 10-14%. Advanta IPO marketing set to begin; FY27 EBITDA growth projected at 14%. Source: ScoutQuest